106 related articles for article (PubMed ID: 3901038)
1. Modulation of gene expression during terminal cell differentiation.
Marks PA; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1985; 191():185-203. PubMed ID: 3901038
[TBL] [Abstract][Full Text] [Related]
2. Modulation of gene expression during terminal cell differentiation: murine erythroleukemia.
Marks PA; Murate T; Kaneda T; Ravetch J; Rifkind RA
Symp Fundam Cancer Res; 1984; 37():327-40. PubMed ID: 6084863
[TBL] [Abstract][Full Text] [Related]
3. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
[TBL] [Abstract][Full Text] [Related]
4. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
5. Regulation of globin gene expression during induced erythroid cell differentiation.
Rifkind RA; Sheffery M; Profous-Juchelka HR; Reuben RC; Marks PA
Prog Clin Biol Res; 1983; 134():183-92. PubMed ID: 6582518
[TBL] [Abstract][Full Text] [Related]
6. Gene expression during terminal differentiation: dexamethasone suppression of inducer-mediated alpha 1- and beta maj-globin gene expression.
Kaneda T; Murate T; Sheffery M; Brown K; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5020-4. PubMed ID: 3860841
[TBL] [Abstract][Full Text] [Related]
7. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
Chen Z; Banks J; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):471-5. PubMed ID: 6952199
[TBL] [Abstract][Full Text] [Related]
8. Hexamethylenebisacetamide-resistant murine erythroleukemia cells have altered patterns of inducer-mediated chromatin changes.
Sheffery M; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3349-53. PubMed ID: 6222378
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
Tsiftsoglou AS; Wong W
Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
[TBL] [Abstract][Full Text] [Related]
10. Induced erythroleukemia differentiation: cellular and molecular aspects.
Rifkind RA; Sheffery M; Marks PA
Blood Cells; 1987; 13(1-2):277-84. PubMed ID: 3311222
[TBL] [Abstract][Full Text] [Related]
11. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
Richon VM; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
[TBL] [Abstract][Full Text] [Related]
12. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
Marks PA; Rifkind RA
Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
14. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells.
Kiyokawa H; Ngo L; Kurosaki T; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901
[TBL] [Abstract][Full Text] [Related]
15. Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment.
Murate T; Kaneda T; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3394-8. PubMed ID: 6203120
[TBL] [Abstract][Full Text] [Related]
16. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
Chen ZX
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
[TBL] [Abstract][Full Text] [Related]
17. Murine erythroleukemia cell differentiation: DNase I hypersensitivity and DNA methylation near the globin genes.
Sheffery M; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1180-4. PubMed ID: 6280172
[TBL] [Abstract][Full Text] [Related]
18. Induction of transformed cells to terminal differentiation.
Marks PA; Sheffery M; Ramsay R; Ikeda K; Rifkind RA
Ann N Y Acad Sci; 1987; 511():246-55. PubMed ID: 3326466
[TBL] [Abstract][Full Text] [Related]
19. Nucleosome disruption precedes transcription and is largely limited to the transcribed domain of globin genes in murine erythroleukemia cells.
Cohen RB; Sheffery M
J Mol Biol; 1985 Mar; 182(1):109-29. PubMed ID: 2582137
[TBL] [Abstract][Full Text] [Related]
20. Gene expression in murine erythroleukemia cells. Transcriptional control and chromatin structure of the alpha 1-globin gene.
Sheffery M; Marks PA; Rifkind RA
J Mol Biol; 1984 Feb; 172(4):417-36. PubMed ID: 6319718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
